By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Drug Company to Congress: The ‘Dog Ate My Homework’
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > Drug Company to Congress: The ‘Dog Ate My Homework’
Medical Ethics

Drug Company to Congress: The ‘Dog Ate My Homework’

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

Just about anyone who has ever been a kid in school recalls trying to make up an excuse believable enough to avoid being punished for not turning in your homework on time. An old favorite is “the dog ate my homework.”

Just about anyone who has ever been a kid in school recalls trying to make up an excuse believable enough to avoid being punished for not turning in your homework on time. An old favorite is “the dog ate my homework.”

A decade ago WilmerHale, a powerful law firm, missed a key deadline far more important than homework. It mistakenly filed a patent extension for its drug company client one day after the 60-day deadline. Rather than being penalized one letter grade like in grade school, the patent extension was rejected by the Patent and Trademark Office, causing the client to lose patent protection five years early for a drug it owned. The drug company sued its law firm, which agreed to cough up $214 million if it cannot somehow reverse the Patent Office’s extension rejection. The powerful law firm and its client have been lobbying Congress to change the law ever since.

In an amendment that is derisively being called “The Dog Ate My Homework Act,” the House agreed to change the way the 60-day patent extension filing deadline is calculated – just to benefit this one powerful law firm and its client. The Senate takes up the debate this week. If this amendment passes, consumers will pay more and have slower access to generic drugs. Let’s hope Congress leaves the law intact rather than demonstrate that rules can be broken when they are inconvenient to powerful lobbying interests.

More Read

Look Out for These Medicare Scams
What Is Personalized Medicine?
HIPAA Basics For Licensed Health Care Professionals: Privacy, Security, and Breach Notification Rules
Another Reason Health Costs Are So High
Pharma Not in Business of Health, Healing, Cures, Wellness
   

TAGGED:pharmaceuticalsWilmerHale
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Best Video Systems for Health Care
How to Choose the Best Video Systems for Health Care
Global Healthcare Technology
April 22, 2026
How Workplace Hygiene Impacts Community Health Outcomes 
How Workplace Hygiene Impacts Community Health Outcomes 
Health
April 21, 2026
care settings
The States Leading on Nurse Practice Authority and Why It Matters for Your Career
Career Nursing
April 14, 2026
brain food matters
Brain Food Matters: How Nutrition Shapes Early Development
Health Infographics
April 14, 2026

You Might also Like

The Dumb and Dumber Files–Man Faked Arm Amputation On Dismemberment Insurance Claim Sentenced to 57 Months in Jail

August 23, 2011
physician ethics
Medical Ethics

Do Physicians Lie?

May 21, 2013

Drug Testing for Welfare Benefits? Two Sides to the Issue

March 10, 2012

Elective Coronary Stenting: A Case in Context

August 3, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?